Manulife (Manufacturers Life Insurance)’s ACELYRIN SLRN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-28,717	Closed	-$70.9K	–	3000
2025 Q1	$70.9K	Buy	28,717 +613	+2%	+$1.46K	﹤0.01%	2774
2024 Q4	$88.2K	Sell	28,104 -701	-2%	-$3.39K	﹤0.01%	2847
2024 Q3	$142K	Sell	28,805 -964	-3%	-$4.98K	﹤0.01%	2770
2024 Q2	$131K	Buy	29,769 +4,163	+16%	+$19.5K	﹤0.01%	2748
2024 Q1	$173K	Buy	25,606 +3,238	+14%	+$24.6K	﹤0.01%	2642
2023 Q4	$167K	Sell	22,368 -33,324	-60%	-$284K	﹤0.01%	2689
2023 Q3	$566K	Buy	55,692 +13,692	+33%	+$291K	﹤0.01%	2073
2023 Q2	$878K	Buy	+42,000	New	+$859K	﹤0.01%	1727

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s SLRN Position: Q2 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 28,717 shares — an estimated $70.9K sold.

Manulife (Manufacturers Life Insurance) first reported a position in SLRN in Q2 2023 and held it in 8 quarters. The position peaked at $878K in Q2 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Manulife (Manufacturers Life Insurance) reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 28,717 ACELYRIN shares in Q2 2025, an estimated $70.9K.
Manulife (Manufacturers Life Insurance) first reported a position in ACELYRIN in Q2 2023 and held it in 8 quarters.
Manulife (Manufacturers Life Insurance)'s ACELYRIN position peaked at $878K in Q2 2023.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.